SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or ...

Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...

Discover how Simplify Health Care ETF outperforms with active healthcare stock selection, offering alpha where others see ...

Hormonal changes associated with menopause may influence the clinical presentation of systemic sclerosis (SSc), according to study findings published in Therapeutic Advances in Musculoskeletal Disease ...

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” ...

ProofPilot, the leading end-to-end clinical experience platform, today announced the acquisition of Lokavant, the clinical trial intelligence company and the premier provider of predictive analytics ...

Phase 2 TOIVA trial successfully met recruitment target, enrolling 16 subjects at leading vascular anomaly centers; top-line data expected in mid-December 2025 Venous malformations are the most common ...

Reaching this stage enables safer care with fewer errors, faster diagnostics, optimised operations, and stronger patient ...

leverages advanced decision science, nudge theory, behavior science and personal technologies to enable remote monitoring and coordinate care for patients across the entire spectrum of chronic and ...

Sleep disturbances are a key contributor to agitation. Poor sleep quality, characterized by frequent awakenings, insomnia, and fragmented rest, affects up to half of dementia patients in advanced ...

Teleflex is launching new products, acquiring Biotronik’s vascular unit, and splitting into two companies to reignite growth.

Background Benign multiple sclerosis (MS), characterised by minimal disability despite long disease duration, remains poorly understood in terms of its determinants and prognostic implications. While ...